Renaissance Technologies’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-511,700
| Closed | -$8.94M | – | 3895 |
|
|
2020
Q4 | $8.94M | Sell |
511,700
-144,300
| -22% | -$2.02M | 0.01% | 1239 |
|
|
2020
Q3 | $7.67M | Buy |
656,000
+73,300
| +13% | +$973K | 0.01% | 1314 |
|
|
2020
Q2 | $7.58M | Buy |
582,700
+85,400
| +17% | +$1.03M | 0.01% | 1391 |
|
|
2020
Q1 | $4.61M | Buy |
497,300
+81,500
| +20% | +$1.14M | ﹤0.01% | 1615 |
|
|
2019
Q4 | $6.9M | Sell |
415,800
-21,776
| -5% | -$353K | 0.01% | 1671 |
|
|
2019
Q3 | $7.28M | Sell |
437,576
-118,424
| -21% | -$1.64M | 0.01% | 1595 |
|
|
2019
Q2 | $7.65M | Buy |
556,000
+263,900
| +90% | +$4.04M | 0.01% | 1576 |
|
|
2019
Q1 | $5.03M | Buy |
292,100
+116,900
| +67% | +$1.85M | ﹤0.01% | 1807 |
|
|
2018
Q4 | $2.24M | Buy |
175,200
+71,900
| +70% | +$1.09M | ﹤0.01% | 2175 |
|
|
2018
Q3 | $1.68M | Buy |
103,300
+82,242
| +391% | +$1.18M | ﹤0.01% | 2364 |
|
|
2018
Q2 | $271K | Buy |
21,058
+9,658
| +85% | +$130K | ﹤0.01% | 2997 |
|
|
2018
Q1 | $142K | Sell |
11,400
-91,600
| -89% | -$1.11M | ﹤0.01% | 3227 |
|
|
2017
Q4 | $1.44M | Sell |
103,000
-62,300
| -38% | -$913K | ﹤0.01% | 2511 |
|
|
2017
Q3 | $2.78M | Sell |
165,300
-76,300
| -32% | -$1.24M | ﹤0.01% | 2112 |
|
|
2017
Q2 | $4.06M | Sell |
241,600
-121,700
| -33% | -$1.82M | 0.01% | 1851 |
|
|
2017
Q1 | $5.63M | Buy |
363,300
+179,600
| +98% | +$2.57M | 0.01% | 1605 |
|
|
2016
Q4 | $2.75M | Sell |
183,700
-15,500
| -8% | -$218K | ﹤0.01% | 2049 |
|
|
2016
Q3 | $2.5M | Buy |
199,200
+72,400
| +57% | +$727K | ﹤0.01% | 2052 |
|
|
2016
Q2 | $1.14M | Buy |
126,800
+45,100
| +55% | +$442K | ﹤0.01% | 2481 |
|
|
2016
Q1 | $810K | Buy |
81,700
+27,800
| +52% | +$285K | ﹤0.01% | 2678 |
|
|
2015
Q4 | $620K | Buy |
53,900
+21,100
| +64% | +$261K | ﹤0.01% | 2660 |
|
|
2015
Q3 | $443K | Buy |
32,800
+7,100
| +28% | +$96.2K | ﹤0.01% | 2660 |
|
|
2015
Q2 | $356K | Buy |
25,700
+6,600
| +35% | +$89.3K | ﹤0.01% | 2820 |
|
|
2015
Q1 | $269K | Buy |
+19,100
| New | +$260K | ﹤0.01% | 2793 |
|
Renaissance Technologies's OXFD Position: Q1 2021 in Review
Renaissance Technologies sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 511,700 shares — an estimated $8.94M sold.
Renaissance Technologies first reported a position in OXFD in Q1 2015 and held it in 24 quarters. The position peaked at $8.94M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Renaissance Technologies reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Renaissance Technologies sold 511,700 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $8.94M.
- Renaissance Technologies first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 24 quarters.
- Renaissance Technologies's Oxford Immunotec Global PLC Ordinary Shares position peaked at $8.94M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.